Insider Stock Trading History of Coughlin Timothy P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Coughlin Timothy P since year 2005. The trader's CIK number is 1376043. At the time of this reporting, Coughlin Timothy P is the Chief Financial Officer of Neurocrine Biosciences Inc . (stock ticker symbol NBIX). See this page for all insider trading activities at Neurocrine Biosciences Inc .

Note that in the past Coughlin Timothy P also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Coughlin Timothy P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-06 NBIX Neurocrine Biosciences Inc Sale 963 43.14 41,543
2017-02-03 NBIX Neurocrine Biosciences Inc Sale 1,500 42.55 63,824
2017-01-17 NBIX Neurocrine Biosciences Inc Sale 1,750 40.65 71,137
2017-01-10 NBIX Neurocrine Biosciences Inc Sale 1,750 43.37 75,897
2016-11-23 FATE Fate Therapeutics Inc Buy 56,390 2.66 149,997
2016-02-03 NBIX Neurocrine Biosciences Inc Sale 1,500 38.06 57,090
2016-01-19 NBIX Neurocrine Biosciences Inc Sale 1,750 46.69 81,707
2016-01-11 NBIX Neurocrine Biosciences Inc Sale 1,750 44.25 77,437
2015-10-16 NBIX Neurocrine Biosciences Inc Sale 25,000 47.78 1,194,500
2015-07-20 NBIX Neurocrine Biosciences Inc Sale 20,000 55.00 1,100,000
2015-07-20 NBIX Neurocrine Biosciences Inc Option Ex 20,000 5.76 115,200
2015-07-13 NBIX Neurocrine Biosciences Inc Option Ex 20,000 5.76 115,200
2015-07-13 NBIX Neurocrine Biosciences Inc Sale 20,000 50.00 1,000,000
2015-06-08 NBIX Neurocrine Biosciences Inc Option Ex 60,000 2.59 155,400
2015-06-08 NBIX Neurocrine Biosciences Inc Sale 60,000 45.08 2,704,800
2015-03-20 NBIX Neurocrine Biosciences Inc Sale 40,000 44.49 1,779,600
2015-03-20 NBIX Neurocrine Biosciences Inc Option Ex 40,000 2.59 103,600
2015-01-16 NBIX Neurocrine Biosciences Inc Sale 1,750 30.81 53,917
2015-01-12 NBIX Neurocrine Biosciences Inc Sale 1,750 28.37 49,647
2015-01-08 NBIX Neurocrine Biosciences Inc Option Ex 10,000 2.59 25,900
2015-01-08 NBIX Neurocrine Biosciences Inc Sale 10,000 27.25 272,500
2014-12-18 NBIX Neurocrine Biosciences Inc Sale 20,000 23.18 463,600
2014-12-19 NBIX Neurocrine Biosciences Inc Sale 10,000 24.02 240,200
2014-12-18 NBIX Neurocrine Biosciences Inc Option Ex 20,000 2.59 51,800
2014-12-19 NBIX Neurocrine Biosciences Inc Option Ex 10,000 2.59 25,900
2014-12-10 NBIX Neurocrine Biosciences Inc Option Ex 20,000 3.85 77,100
2014-12-10 NBIX Neurocrine Biosciences Inc Sale 20,000 21.48 429,500
2014-11-28 NBIX Neurocrine Biosciences Inc Sale 10,000 20.14 201,400
2014-10-31 NBIX Neurocrine Biosciences Inc Sale 10,000 19.00 190,000
2014-10-30 NBIX Neurocrine Biosciences Inc Sale 10,000 18.62 186,200
2014-10-28 NBIX Neurocrine Biosciences Inc Sale 10,000 18.00 180,000
2014-01-10 NBIX Neurocrine Biosciences Inc Sale 1,750 18.56 32,479
2014-01-07 NBIX Neurocrine Biosciences Inc Sale 70,000 16.75 1,172,500
2013-08-21 NBIX Neurocrine Biosciences Inc Sale 19,035 15.05 286,476
2013-08-05 NBIX Neurocrine Biosciences Inc Sale 10,965 14.99 164,365
2011-02-28 NBIX Neurocrine Biosciences Inc Sale 12,320 6.83 84,108
2010-03-01 NBIX Neurocrine Biosciences Inc Sale 12,650 2.53 31,966
2010-01-12 NBIX Neurocrine Biosciences Inc Sale 8,697 2.52 21,951
2009-03-30 NBIX Neurocrine Biosciences Inc Sale 12,117 3.43 41,537
2009-01-13 NBIX Neurocrine Biosciences Inc Sale 8,463 3.38 28,647
2008-02-12 NBIX Neurocrine Biosciences Inc Sale 7,857 5.03 39,520

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coughlin Timothy P (Chief Financial Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.